Home/Stocks/Pharmaceuticals

GSK PLC

GSK·Pharmaceuticals·Market Cap £88.3b

Rank #12 of 48

Data from Excel Model · 48 Stocks Analysed

£21.67

+18.77% YTD

Target: £20.89(-3.6%)

52W: £12.43 - £22.82

Score Analysis

GSK PLC is ranked #12 out of 48 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

19/48

Average Score

Liquidity

Fair24/48

Valuation

Good13/48

Profitability

Weak39/48

Solvency

Excellent6/48

Mkt Trading

Excellent11/48

Technical

Fair22/48

1. Valuation

Score: 13/48

Is GSK undervalued compared to its peers and fair value metrics?

3/5

valuation criteria met

✓

FY26e P/E Ratio

12.2xRank 12/48

✓

FY27e P/E Ratio

11.1xRank 11/48

✗

Price-to-Book

5.31xRank 29/48

✓

Price-to-Tangible Book

N/ARank 1/48

✗

EV/EBITDA

8.7xRank 20/48

Key Valuation Metrics

Current P/E

15.4x

Price-to-Earnings

FY26e P/E

12.2x

Forward estimate

FY27e P/E

11.1x

Forward estimate

P/B Ratio

5.31x

Price-to-Book

P/TBV

N/A

Price-to-Tangible Book

EV/EBITDA

8.7x

Enterprise Value

FY26e EV/EBITDA

8.8x

Forward estimate

FY27e EV/EBITDA

8.3x

Forward estimate

Analyst Consensus Target

Current Price

£21.67

Consensus Target

£20.89

Potential

-3.6%

Target

Bloomberg Median Target: £20.00

2. Profitability

Score: 39/48

How profitable is GSK relative to its peers?

0/6

profitability criteria met

✗

TTM Profit Margin

17.5%Rank 35/48

✗

Current ROE

38.0%Rank 43/48

✗

Current ROA

9.5%Rank 38/48

✗

FY26e EPS

1.78Rank 31/48

✗

TTM EPS

1.41Rank 29/48

✗

Net Income Growth

Rank 49Rank 49/48

Profit Margin

17.5%

ROE

38.0%

FY27e ROE

39.4%

ROA

9.5%

Earnings Per Share

3. Financial Health

Score: 6/48

How strong is GSK's balance sheet and financial position?

1/6

solvency criteria met

✗

Debt-to-Equity

111.1%Rank 22/48

✗

Altman Z-Score

2.82Rank 23/48

✗

Z-Score Trend

Rank 49Rank 49/48

✗

Amihud Illiquidity

Rank 49Rank 49/48

✗

Intangible/Asset

Rank 49Rank 49/48

✓

R&D/Sales

Rank 2Rank 2/48

Key Health Metrics

Quick Ratio

0.42

Below 1.0

Cash Ratio

0.16

Debt/Equity

111%

FCF Margin

6.7%

Altman Z-Score

2.82

Grey Zone

01.812.995+

4. Dividend

GSK pays a dividend yield of 3.05%.

Current Yield

3.05%

FY27e Yield

3.18%

FY26e DPS

0.690

FY27e DPS

N/A

Dividend Per Share Forecast

5. Technical Analysis

Score: 22/48

What do the technical indicators say about GSK?

1/4

technical criteria met

✗

CMP vs 52W High

-5.0%Rank 27/48

✓

CMP vs 52W Low

74.4%Rank 16/48

✗

RSI 14 Day

60.1Rank 20/48

✗

MA(50) > MA(200)

Yes (Bullish)Rank 24/48

RSI (14 Day)

60.1

Bullish

0 (Oversold)50100 (Overbought)

Moving Averages

MA 30-Day£20.36

MA 50-Day£19.60

MA 200-Day£16.52

SignalGolden Cross (Bullish)

MACD78.64

Risk Metrics

Beta

1.07

Higher volatility

3-Yr Std Dev

195.4%

5-Yr Std Dev

192.6%

6. Market Trading

Score: 11/48

How liquid and actively traded is GSK?

2/4

market trading criteria met

✓

5D Avg Volume

5.7MRank 18/48

✓

3M Avg Volume

5.8MRank 15/48

✗

Volume Trend

-1.2%Rank 49/48

✗

Beta

1.07Rank 21/48

Shares Outstanding

4073.1m

Free Float

100.0%

Enterprise Value

$102.2b

Trading Volume

7. Peer Comparison

How does GSK compare to other Pharmaceuticals stocks?

Overall Rank Comparison

Factor Score Comparison

Stock	Rank	Liquidity	Valuation	Profitability	Solvency	Mkt Trading	Technical
GSK	#12	24	13	39	6	11	22
AZN	#11	33	38	46	7	34	8

Similar Stocks

Other top-ranked stocks in the Pharmaceuticals sector